Fatal Adenoviral Outcomes: Credit must be given to the study for uncovering that all five deaths recorded in the cohort were ...

Current Infectious Disease Society of America guidelines for the treatment of invasive candidiasis recommend a minimum ...

Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...

Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...

Among patients with AAV who develop DAH, a subset also experience VTE, highlighting the complex care required to manage this population.

The study links facial aging rates to cancer outcomes, suggesting a new prognostic tool that could personalize treatment and ...

With no known cure for focal segmental glomerulosclerosis (FSGS), many affected patients opt for kidney transplant. But even ...

Point-of-care testing identifies ARDS inflammatory subphenotypes in real time, offering insights into patient prognosis and mortality risks.

Treatment with the ustekinumab biosimilar AVT04 was safe and effective for patients with plaque PsO, regardless of previous use of the reference product.

Using a more pragmatic classification system than the current standard provided clearer discrimination between disease ...

That question is becoming more urgent. According to a major new study published in Science, advanced artificial intelligence ...

Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic ...